The importance of growth kinetic analysis in determining bacterial susceptibility against antibiotics and silver nanoparticles

Frontiers in Microbiology

Volumn 5, Issue NOV, 2014, Pages

  Theophel, Karsten ^a   Schacht, Veronika J ^a,c   Schlüter, Michael ^a   Schnell, Sylvia ^a   Stingu, Catalina Suzana ^b   Schaumann, Reiner ^b   Bunge, Michael ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Antibiotic susceptibility testing; Antimicrobial nanoparticles; Enterococcus; Growth dynamics; Hormesis; Silver; Subinhibitory

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFOXITIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; ERYTHROMYCIN; FOSFOMYCIN; FUSIDIC ACID; LINEZOLID; MOXIFLOXACIN; OXACILLIN; PENICILLIN G; PSEUDOMONIC ACID; REACTIVE OXYGEN METABOLITE; RIFAMPICIN; SILVER NANOPARTICLE; STREPTOMYCIN; TEICOPLANIN DERIVATIVE; TIGECYCLINE; VANCOMYCIN;

AMPLITUDE MODULATION; ARTICLE; CANCER INHIBITION; CELL MEMBRANE; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENTEROCOCCUS FAECIUM; GENETIC SUSCEPTIBILITY; GROWTH RATE; GROWTH STIMULATION; INCUBATION TIME; KINETICS; MICROBIAL GROWTH; NONHUMAN; OPTICAL DENSITY; POLYMERASE CHAIN REACTION; PREVALENCE; SEQUENCE ANALYSIS; STRAIN IDENTIFICATION;

EID: 84987786640     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2014.00544     Document Type: Article

References (51)

1. Aminov, R. I. (2009). The role of antibiotics and antibiotic resistance in nature. Environ. Microbiol. 11, 2970-2988. doi: 10.1111/j.1462-2920.2009.01972.x
2. Andersson, D. I., and Hughes, D. (2011). Persistence of antibiotic resistance in bacterial populations. FEMS Microbiol. Rev. 35, 901-911. doi: 10.1111/j.1574-6976.2011.00289.x
3. Arias, C. A., and Murray, B. E. (2012). The rise of the Enterococcus: beyond vancomycin resistance. Nat. Rev. Microbiol. 10, 266-278. doi: 10.1038/nrmicro2761
4. Barton, M. D. (2000). Antibiotic use in animal feed and its impact on human health. Nutr. Res. Rev. 13, 279-299. doi: 10.1079/095442200108729106
5. Carlson, C., Hussain, S. M., Schrand, A. M., Braydich-Stolle, L. K., Hess, K. L., Jones, R. L., et al. (2008). Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J. Phys. Chem. B 112, 13608-13619. doi: 10.1021/jp712087m
6. Chopra, I. (2007). The increasing use of silver-based products as antimicrobial agents: a useful development or a cause for concern? J. Antimicrob. Chemother. 59, 587-590. doi: 10.1093/jac/dkm006
7. Clinical and Laboratory Standards Institute [CLSI]. (2012). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Ninth Edition. CLSI document M07-A9. Wayne, PA: Clinical and Laboratory Standards Institute.
8. Clinical and Laboratory Standards Institute [CLSI]. (2013). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement. CLSI document M100-S23. Wayne, PA: Clinical and Laboratory Standards Institute.
9. Czock, D., Markert, C., Hartman, B., and Keller, F. (2009). Pharmacokinetics and pharmacodynamics of antimicrobial drugs. Expert Opin. Drug Met. Toxicol. 5, 475-487. doi: 10.1517/17425250902913808
10. Davies, J., and Davies, D. (2010). Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. Rev. 74, 417-433. doi: 10.1128/MMBR.00016-10
11. Davies, J., Spiegelman, G. B., and Yim, G. (2006). The world of subinhibitory antibiotic concentrations. Curr. Opin. Microbiol. 9, 445-453. doi: 10.1016/j.mib.2006.08.006
12. Eber, M. R., Laxminarayan, R., Perencevich, E. N., and Malani, A. (2010). Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia. Arch. Intern. Med. 170, 347-353. doi: 10.1001/archinternmed.2009.509
13. European Antimicrobial Resistance Surveillance System [EARSS] Annual Report, (2008). On-going surveillance of S. pneumoniae, S. aureus, E. coli, E. faecium, E. faecalis, K. pneumoniae, P. aeruginosa, ECDC (European Centre for Disease Prevention and Control). Bilthoven: Rijksinstituut voor Volksgezondheid en Milieu RIVM.
14. European Committee for Antimicrobial Susceptibility Testing [EUCAST] of the European Society of Clinical Microbiology and Infectious Diseases [ESCMID], (2003). EUCAST Discussion Document E.Dis.5.1. Determination of minimum inhibitory concentrations (MIC's) of antibacterial agents by broth dilution. Clin. Microbiol. Infec. 9, 1-7.
15. Fisher, K., and Phillips, C. (2009). The ecology, epidemiology and virulence of Enterococcus. Microbiol. 155, 1749-1757. doi: 10.1099/mic.0.026385-0
16. Häussler, S., Ziesing, S., Rademacher, G., Hoy, L., and Weissbrodt, H. (2003). Evaluation of the Merlin, Micronaut system for automated antimicrobial susceptibility testing of Pseudomonas aeruginosa and Burkholderia species isolated from cystic fibrosis patients. Eur. J. Clin. Microbiol. 22, 496-500. doi: 10.1007/s10096-003-0974-7
17. Jorgensen, J. H., and Ferraro, M. J. (2009). Antimicrobial susceptibility testing: a review of general principles and contemporary practices. Clin. Infect. Dis. 49, 1749-1755. doi: 10.1086/647952
18. Klare, I., Konstabel, C., Badstübner, D., Werner, G., and Witte, W. (2003). Occurrence and spread of antibiotic resistances in Enterococcus faecium. Int. J. Food Microbiol. 88, 269-290. doi: 10.1016/S0168-1605(03)00190-9
19. Kohanski, M. A., Dwyer, D. J., and Collins, J. J. (2010). How antibiotics kill bacteria: from targets to networks. Nat. Rev. Microbiol. 8, 423-435. doi: 10.1038/nrmicro2333
20. Kümmerer, K. (2009a). Antibiotics in the aquatic environment - A review - Part I. Chemosphere 75, 417-434. doi: 10.1016/j.chemosphere.2008.11.086
21. Kümmerer, K. (2009b). Antibiotics in the aquatic environment - A review - Part II. Chemosphere 75, 435-441. doi: 10.1016/j.chemosphere.2008.12.006
22. Lane, D. J. (1991). "16S/23S rRNA sequencing". in Nucleic Acid Techniques in Bacterial Systematics, eds E. Stackebrandt and M. Goodfellow (New York, NY: John Wiley and Sons, Inc), 115-175.
23. Leclercq, R., Canton, R., Brown, D. F. J., Giske, C. G., Heisig, P., MacGowan, A. P., et al. (2013). EUCAST expert rules in antimicrobial susceptibility testing. Clin. Microbiol. Infec. 19, 141-160. doi: 10.1111/j.1469-0691.2011.03703.x
24. Lester, C. H., Frimodt-Møller, N., Sørensen, T. L., Monnet, D. L, . and Hammerum, A. A. (2006). In vivo transfer of the vanA resistance gene from an Enterococcus faecium isolate of animal origin to an E. faecium isolate of human origin in the intestines of human volunteers. Antimicrob. Agents Chemother. 50, 596-599. doi: 10.1128/AAC.50.2.596-599.2006
25. Linares, J. F., Gustafsson, I., Baquero, F., and Martinez, J. L. (2006). Antibiotics as intermicrobial signaling agents instead of weapons. Proc. Natl. Acad. Sci. U.S.A. 103, 19484-19489. doi: 10.1073/pnas.0608949103
26. Liu, J. Y., and Hurt, R. H. (2010). Ion release kinetics and particle persistence in aqueous nano-silver colloids. Environ. Sci. Technol. 44, 2169-2175. doi: 10.1021/es9035557
27. Marambio-Jones, C., and Hoek, E. M. V. (2010). A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J. Nanopart. Res. 12, 1531-1551. doi: 10.1007/s11051-010-9900-y
28. Marshall, B. M., and Levy, S. B. (2011). Food animals and antimicrobials: impacts on human health. Clin. Microbiol. Rev. 24, 718-733. doi: 10.1128/CMR.00002-11
29. Martinez, J. L. (2009a). The role of natural environments in the evolution of resistance traits in pathogenic bacteria. Proc. R. Soc. B Biol. Sci. 276, 2521-2530.
30. Martinez, J. L. (2009b). Environmental pollution by antibiotics and by antibiotic resistance determinants. Environ. Pollut. 157, 2893-2902. doi: 10.1016/j.envpol.2009.05.051
31. Martinez, J. L., Fajardo, A., Garmendia, L., Hernandez, A., Linares, J. F., Martinez-Solano, L., et al. (2009). A global view of antibiotic resistance. FEMS Microbiol. Rev. 33, 44-65. doi: 10.1111/j.1574-6976.2008.00142.x
32. Miller, W. S., Green, C. A., and Kitchen, H. (1945). Biphasic action of penicillin and other sulphonamide similarity. Nature 155, 210-211. doi: 10.1038/155210a0
33. Nau, R., Sörgel, F., and Eiffert, H. (2010). Penetration of drugs through the blood-cerebrospinal fluid/blood-brain barrier for treatment of central nervous system infections. Clin. Microbiol. Rev. 23, 858-883. doi: 10.1128/CMR.00007-10
34. Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., et al. (2009). Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater 8, 543-557. doi: 10.1038/nmat2442
35. Nel, A., Xia, T., Mädler, L., and Li, N. (2006). Toxic potential of materials at the nanolevel. Science 311, 622-627. doi: 10.1126/science.1114397
36. Nikaido, H. (2009). Multidrug resistance in bacteria. Annu. Rev. Biochem. 78, 119-146. doi: 10.1146/annurev.biochem.78.082907.145923
37. Rizzo, L., Manaia, C., Merlin, C., Schwartz, T., Dagot, C., Ploy, M. C., et al. (2013). Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: a review. Sci. Total Environ. 447, 345-360. doi: 10.1016/j.scitotenv.2013.01.032
38. Rodriguez-Rojas, A., Rodriguez-Beltran, J., Couce, A., and Blazquez, J. (2013). Antibiotics and antibiotic resistance: a bitter fight against evolution. Int. J. Med. Microbiol. 303, 293-297. doi: 10.1016/j.ijmm.2013.02.004
39. Sarmah, A. K., Meyer, M. T., and Boxall, A. B. A. (2006). A global perspective on the use, sales, exposure pathways, occurrence, fate and effects of veterinary antibiotics (VAs) in the environment. Chemosphere 65, 725-759. doi: 10.1016/j.chemosphere.2006.03.026
40. Schacht, V. J., Neumann, L. V., Sandhi, S. K., Chen, L., Henning, T., Klar, P. J., et al. (2013). Effects of silver nanoparticles on microbial growth dynamics. J. Appl. Microbiol. 114, 25-35. doi: 10.1111/jam.12000
41. Senior, K., Müller, S., Schacht, V. J., and Bunge, M. (2012). Antimicrobial precious-metal nanoparticles and their use in novel materials. Recent Pat. Food Nutr. Agric. 4, 200-209. doi: 10.2174/2212798411204030200
42. Silver, S. (2003). Bacterial silver resistance: molecular biology and uses and misuses of silver compounds. FEMS Microbiol. Rev. 27, 341-353. doi: 10.1016/S0168-6445(03)00047-0
43. Singer, R. S., Cox, L. A., Dickson, J. S., Hurd, H. S., Phillips, I., and Miller, G. Y. (2007). Modeling the relationship between food animal health and human foodborne illness. Prev. Vet. Med. 79, 186-203. doi: 10.1016/j.prevetmed.2006.12.003
44. Stepanauskas, R., Glenn, T. C., Jagoe, C. H., Tuckfield, R. C., Lindell, A. H., King, C. J., et al. (2006). Coselection for microbial resistance to metals and antibiotics in freshwater microcosms. Environ. Microbiol. 8, 1510-1514. doi: 10.1111/j.1462-2920.2006.01091.x
45. Su, H. L., Chou, C. C., Hung, D. J., Lin, S. H., Pao, I. C., Lin, H. J., et al. (2009). The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay. Biomaterials 30, 5979-5987. doi: 10.1016/j.biomaterials.2009.07.030
46. Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M., and Kumar, S. (2011). MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28, 2731-2739. doi: 10.1093/molbev/msr121
47. The European Committee on Antimicrobial Susceptibility Testing [EUCAST]. (2014). Breakpoints Tables for Interpretation of MIC's and Zone Diameters. Version 4.0. Available at: http://www.eucast.org.
48. Theuretzbacher, U. (2007). Tissue penetration of antibacterial agents: how should this be incorporated into pharmacodynamic analyses? Curr. Opin. Pharmacol. 7, 498-504. doi: 10.1016/j.coph.2007.05.003
49. Uttley, A. H. C., Collins, C. H., Naidoo, J., and George, R. C. (1988). Vancomycin-resistant enterococci. Lancet 1, 57-58. doi: 10.1016/S0140-6736(88)91037-9
50. Victorian Advisory Committee on Infection Control [VACIC]. (2012). Vancomycin Resistant Enterococci (VRE) in Victorian Health Facilities. Victorian Department of Health, Melbourne. Available at: http://www.health.vic.gov.au/infectionprevention/downloads/vre-report.pdf (accessed June 24, 2013).
51. Zhang, X. X., Zhang, T., and Fang, H. (2009). Antibiotic resistance genes in water environment. Appl. Microbiol. Biotechnol. 82, 397-414. doi: 10.1007/s00253-008-1829-z